tcbio: the income statement

MyFinsight

For the quarter ending 2025-09-30, TCBIO made $908,617K in revenue. $100,897K in net income. Net profit margin of 11.10%.

Unit: Thousand (K) dollars (except for numbers of shares and EPS)

Income Statement	2025-09-30
Interest and fees on loans	379,017
Investment securities	49,396
Interest bearing cash and cash equivalents	32,202
Total interest income	460,615
Deposits	180,779
Short-term borrowings	534
Long-term debt	7,531
Total interest expense	188,844
Net interest income	271,771
Provision for credit losses	12,000
Net interest income after provision for credit losses	259,771
Service charges on deposit accounts	8,111
Wealth management and trust fee income	3,989
Brokered loan fees	2,419
Investment banking and advisory fees	33,985
Trading income	7,238
Available-for-sale debt securities losses	0
Other	12,841
Total non-interest income	68,583
Salaries and benefits	119,856
Occupancy expense	11,828
Marketing	3,412
Legal and professional	12,474
Communications and technology	24,594
Federal deposit insurance corporation insurance assessment	5,198
Other	13,213
Total non-interest expense	190,575
Income/(loss) before income taxes	137,779
Income tax expense/(benefit)	32,569
Net income/(loss)	105,210
Preferred stock dividends	4,313
Net income/(loss) available to common stockholders	100,897

Basic earnings per common shareweighted average common shares	45,708,185
Basic earnings/(loss) per common share (in usd per share)	2.21
Diluted earnings/(loss) per common share (in usd per share)	2.18
Dilutive earnings per common shareweighted average diluted common shares	46,233,167